Mostly Markets
Subscribe
Stocks/Health Care/Health Care Equipment

Boston ScientificBSX

Health Care Equipment · Marlborough, Massachusetts · In the S&P 500
High qualityCheaper than peers
$41.98−1.66%After hours: $42.00 (+0.05%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 58.1% over 1 year
Boston Scientific over 1 yearDaily close, $, to 30 Oct 2026
$60$80$100Nov2026MarMayJulSep$41.98$50$75$100NovMarJul$41.98
Source: Nasdaq daily closes
Market value$60.84B
Price to earnings17.8x
Forward P/E13.8x
Dividend yield–
Year to date−56.0%
One year−58.1%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$41.58$104.98

Quality and valuation

How Boston Scientific compares with other health care stocks. A description, not a recommendation.

Boston Scientific and 7 health care equipment peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: stronger than mostValuation: cheaper than most

A stronger business than most health care companies, priced below most of them.

Boston Scientific trades at 13.8 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +13.5% vs +7.8%
  • Keeps more of each sale (gross margin): 69.9% vs 65.3%
  • More profitable (operating margin): 19.8% vs 13.3%
  • Turns more of its sales into cash: 17.3% vs 15.9%
BSX trades at 13.8x forward earnings, below the sector medianForward p/e, Health Care Equipment peers
BSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xIDXX35.1xISRG37.5xSector median 19.1xBSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xIDXX35.1xISRG37.5xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 17.0x earnings, BSX is cheaper than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
40x60x80xAverage 53.8x2025202617.0x50xAverage 53.8x2025202617.0x
Source: Nasdaq prices; SEC filings

Financials

From Boston Scientific's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 7.5% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0bn$2bn$4bnQ3 ’24Q1 ’25Q3 ’25$5.4bnQ2 ’26$0bn$2bn$4bnQ3 ’24Q1 ’25Q3 ’25$5.4bnQ2 ’26
Source: SEC filings
Growth slowed to +7.5% last quarterRevenue growth, year on year, %
0%10%20%Q3 ’24Q1 ’25Q3 ’257.5%Q2 ’260%10%20%Q3 ’24Q1 ’25Q3 ’257.5%Q2 ’26
Source: SEC filings
Operating margin was 21.6% last quarterOperating income as a share of revenue, %
0%10%20%Q3 ’24Q1 ’25Q3 ’2521.6%Q2 ’260%10%20%Q3 ’24Q1 ’25Q3 ’2521.6%Q2 ’26
Source: SEC filings
Free cash flow was $3.6 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$0.0bn$0.5bn$1.0bnQ3 ’24Q1 ’25Q3 ’25$1.3bnQ2 ’26$0.0bn$0.5bn$1.0bnQ3 ’24Q1 ’25Q3 ’25$1.3bnQ2 ’26
Source: SEC filings
Last 12 monthsBSXSector median
Revenue growth+13.5%+7.8%
Gross margin69.9%65.3%
Operating margin19.8%13.3%
Free cash flow margin17.3%15.9%
Price to earnings17.8x30.2x

Stories on Boston Scientific

Thursday, 22 October
Chart

Three of the S&P 500's Five Best Stocks This Year Make AI Hardware

Sandisk, Dell and Micron are up 200% to 431% in 2026, behind only Moderna, while AppLovin has lost 60.8%, the worst in the index.

SNDK▼ 8.5%
Screens of market charts

Similar companies

Health Care Equipment, by market value.

CompanyPriceTodayYTDValue
ABTAbbott Laboratories$106.20+1.56%−15.2%$184B
ISRGIntuitive Surgical$432.01−3.73%−23.7%$150B
MDTMedtronic$96.54−0.59%+0.5%$123B
SYKStryker$291.86−6.38%−17.0%$112B
BDXBecton Dickinson$197.88−0.23%+27.4%$53.90B
EWEdwards Lifesciences$92.01−2.57%+7.9%$53.03B
IDXXIdexx Laboratories$551.21−4.30%−18.5%$43.42B
GEHCGE HealthCare$76.57+0.20%−6.6%$34.62B